BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 36139145)

  • 1. Phytochemicals in Inhibition of Prostate Cancer: Evidence from Molecular Mechanisms Studies.
    Hao Q; Wu Y; Vadgama JV; Wang P
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactive natural products against prostate cancer: mechanism of action and autophagic/apoptotic molecular pathways.
    Gioti K; Tenta R
    Planta Med; 2015 May; 81(7):543-62. PubMed ID: 25875508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytocompounds from the Medicinal and Dietary Plants: Multi-target Agents for Cervical Cancer Prevention and Therapy.
    Shoaib S; Islam N; Yusuf N
    Curr Med Chem; 2022; 29(26):4481-4506. PubMed ID: 35232338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment.
    Gao Q; Feng J; Liu W; Wen C; Wu Y; Liao Q; Zou L; Sui X; Xie T; Zhang J; Hu Y
    Adv Drug Deliv Rev; 2022 Sep; 188():114445. PubMed ID: 35820601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice.
    Zhou JR; Gugger ET; Tanaka T; Guo Y; Blackburn GL; Clinton SK
    J Nutr; 1999 Sep; 129(9):1628-35. PubMed ID: 10460196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into the Biological Roles and Mechanisms of Phytochemicals in Different Types of Cancer: Targeting Cancer Therapeutics.
    Majrashi TA; Alshehri SA; Alsayari A; Muhsinah AB; Alrouji M; Alshahrani AM; Shamsi A; Atiya A
    Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target to apoptosis: a hopeful weapon for prostate cancer.
    Tang DG; Porter AT
    Prostate; 1997 Sep; 32(4):284-93. PubMed ID: 9288188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis and Anti-Angiogenic Treatment in Prostate Cancer: Mechanisms of Action and Molecular Targets.
    Ioannidou E; Moschetta M; Shah S; Parker JS; Ozturk MA; Pappas-Gogos G; Sheriff M; Rassy E; Boussios S
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer Activity and Underlying Mechanism of Phytochemicals against Multiple Myeloma.
    Kang B; Park H; Kim B
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31075954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol and Prostate Cancer: The Power of Phytochemicals.
    Zaffaroni N; Beretta GL
    Curr Med Chem; 2021; 28(24):4845-4862. PubMed ID: 33371831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo.
    Dorai T; Cao YC; Dorai B; Buttyan R; Katz AE
    Prostate; 2001 Jun; 47(4):293-303. PubMed ID: 11398177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy.
    McCarty MF
    Integr Cancer Ther; 2004 Dec; 3(4):349-80. PubMed ID: 15523106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bee Venom Components as Therapeutic Tools against Prostate Cancer.
    Badawi JK
    Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34067049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytochemicals in Prostate Cancer: From Bioactive Molecules to Upcoming Therapeutic Agents.
    Salehi B; Fokou PVT; Yamthe LRT; Tali BT; Adetunji CO; Rahavian A; Mudau FN; Martorell M; Setzer WN; Rodrigues CF; Martins N; Cho WC; Sharifi-Rad J
    Nutrients; 2019 Jun; 11(7):. PubMed ID: 31261861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.
    Li L; Zhu Z; Joshi B; Porter AT; Tang DG
    Anticancer Res; 1999; 19(1A):51-60. PubMed ID: 10226524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of action and chemosensitization of tumor cells in ovarian cancer by phytochemicals: A narrative review on pre-clinical and clinical studies.
    Barboza JR; Pereira FAN; Vasconcelos CC; de Sousa Ribeiro MN; Lopes AJO
    Phytother Res; 2023 Jun; 37(6):2484-2512. PubMed ID: 37098735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating molecular and cellular targets and the antiprostate cancer potentials of promising phytochemicals: a review.
    Khan H; Rais J; Afzal M; Arshad M
    Anticancer Drugs; 2023 Sep; 34(8):910-915. PubMed ID: 36995078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
    Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
    BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-angiogenesis Potential of Phytochemicals for the Therapeutic Management of Tumors.
    Munir S; Shah AA; Shahid M; Ahmed MS; Shahid A; Rajoka MSR; Akash MSH; Akram M; Khurshid M
    Curr Pharm Des; 2020; 26(2):265-278. PubMed ID: 31886747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy-modulating phytochemicals in cancer therapeutics: Current evidences and future perspectives.
    Patra S; Mishra SR; Behera BP; Mahapatra KK; Panigrahi DP; Bhol CS; Praharaj PP; Sethi G; Patra SK; Bhutia SK
    Semin Cancer Biol; 2022 May; 80():205-217. PubMed ID: 32450139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.